fluorodeoxyglucose f18 has been researched along with Cryptogenic Fibrosing Alveolitis in 12 studies
| Timeframe | Studies, this research(%) | All Research% |
|---|---|---|
| pre-1990 | 0 (0.00) | 18.7374 |
| 1990's | 0 (0.00) | 18.2507 |
| 2000's | 0 (0.00) | 29.6817 |
| 2010's | 8 (66.67) | 24.3611 |
| 2020's | 4 (33.33) | 2.80 |
| Authors | Studies |
|---|---|
| Fukui, M; Hattori, A; Matsunaga, T; Nomura, K; Suzuki, K; Takamochi, K | 1 |
| Abe, S; Ikeda, N; Masuno, R; Ohira, T; Shimada, Y; Yamamichi, T; Yoshimura, A | 1 |
| Andreev, DN; Bellaye, PS; Bonniaud, P; Bouchard, A; Cochet, A; Collin, B; Frenay, J; Goirand, F; Guillemin, M; Helbling, A; Kucheryavy, YA; Mayev, IV; Moreau, M; Mothes, C; Oudot, A; Tanguy, J | 1 |
| Aigbirhio, F; Emond, E; Endozo, R; Erlandsson, K; Fraioli, F; Ganeshan, B; Groves, AM; Hoath, J; Holman, B; Hutton, BF; Khan, S; Lukey, PT; Maher, TM; Porter, JC; Rashidnasab, A; Rodriguez-Justo, M; Screaton, NJ; Shortman, RI; Thielemans, K; Win, T | 1 |
| Aubier, M; Borie, R; Crestani, B; Debray, MP; Dieudonné, A; Justet, A; Laurent-Bellue, A; Lebtahi, R; Thabut, G | 1 |
| Aliyu, SA; Archibald, SJ; Avery, G; Cawthorne, C; Crooks, MG; Hart, SP; Kadir, T; Morice, AH; Willaime, JMY | 1 |
| Bondue, B; Castiaux, A; Doumont, G; Egrise, D; Goldman, S; Huaux, F; Lacroix, S; Mathey, C; Sherer, F; Van Simaeys, G | 1 |
| Afaq, A; Ell, PJ; Endozo, R; Groves, AM; Hutton, BF; Lambrou, T; Lukey, P; Maher, TM; Porter, JC; Screaton, NJ; Shortman, RI; Thomas, BA; Win, T | 1 |
| Fung, SL; Ho, JC; Lee, EY; Wong, CS; Yan, PK | 1 |
| Ameshima, S; Anzai, M; Demura, Y; Ishizaki, T; Ishizuka, T; Kadowaki, M; Kiyono, Y; Morikawa, M; Okazawa, H; Tsuchida, T; Tsujikawa, T; Umeda, Y | 1 |
| Endozo, R; Groves, AM; Hutton, BF; Kayani, I; Lambrou, T; Lukey, P; Maher, TM; Porter, JC; Screaton, NJ; Shortman, RI; Win, T | 1 |
| Dickson, J; Ell, PJ; Endozo, R; Groves, AM; Kayani, I; Porter, J; Reubi, JC; Screaton, NJ; Shortman, RI; Wild, D; Win, T | 1 |
1 review(s) available for fluorodeoxyglucose f18 and Cryptogenic Fibrosing Alveolitis
2 trial(s) available for fluorodeoxyglucose f18 and Cryptogenic Fibrosing Alveolitis
| Article | Year |
|---|---|
18F-Fluorodeoxyglucose positron emission tomography pulmonary imaging in idiopathic pulmonary fibrosis is reproducible: implications for future clinical trials.
Topics: Aged; Female; Fluorodeoxyglucose F18; Humans; Idiopathic Pulmonary Fibrosis; Lung; Male; Multimodal Imaging; Positron-Emission Tomography; Reproducibility of Results; Time Factors; Tomography, X-Ray Computed | 2012 |
Novel positron emission tomography/computed tomography of diffuse parenchymal lung disease combining a labeled somatostatin receptor analogue and 2-deoxy-2[18F]fluoro-D-glucose.
Topics: Aged; Female; Fluorodeoxyglucose F18; Humans; Idiopathic Interstitial Pneumonias; Idiopathic Pulmonary Fibrosis; Lung Diseases, Interstitial; Male; Multimodal Imaging; Positron-Emission Tomography; Receptors, Somatostatin; Staining and Labeling; Tomography, X-Ray Computed | 2012 |
9 other study(ies) available for fluorodeoxyglucose f18 and Cryptogenic Fibrosing Alveolitis
| Article | Year |
|---|---|
Diagnostic Value of Nodal Staging of Lung Cancer With Usual Interstitial Pneumonia Using PET.
Topics: Carcinoma, Non-Small-Cell Lung; Fluorodeoxyglucose F18; Humans; Idiopathic Pulmonary Fibrosis; Lung Neoplasms; Lymph Nodes; Neoplasm Staging; Positron Emission Tomography Computed Tomography; Positron-Emission Tomography; Retrospective Studies; Sensitivity and Specificity | 2022 |
Association between F-18 fluorodeoxyglucose uptake of noncancerous lung area and acute exacerbation of interstitial pneumonia in patients with lung cancer after resection.
Topics: Adult; Aged; Aged, 80 and over; Disease Progression; Female; Fluorodeoxyglucose F18; Humans; Idiopathic Pulmonary Fibrosis; Lung Neoplasms; Male; Middle Aged; Pneumonectomy; Positron Emission Tomography Computed Tomography; Predictive Value of Tests; Radiopharmaceuticals; Reproducibility of Results; Respiration; Risk Assessment; Risk Factors; Treatment Outcome; Young Adult | 2020 |
Measurement of hypoxia in the lung in idiopathic pulmonary fibrosis: an F-MISO PET/CT study.
Topics: Fluorodeoxyglucose F18; Humans; Hypoxia; Idiopathic Pulmonary Fibrosis; Lung; Positron Emission Tomography Computed Tomography | 2021 |
[
Topics: Comorbidity; Disease-Free Survival; Fluorodeoxyglucose F18; France; Humans; Idiopathic Pulmonary Fibrosis; Incidence; Middle Aged; Positron Emission Tomography Computed Tomography; Prognosis; Radiopharmaceuticals; Reproducibility of Results; Risk Factors; Sensitivity and Specificity; Smoking; Survival Rate | 2017 |
Textural analysis demonstrates heterogeneous [
Topics: Aged; Aged, 80 and over; Diagnosis, Differential; Female; Fluorodeoxyglucose F18; Humans; Idiopathic Pulmonary Fibrosis; Lung; Lung Neoplasms; Male; Middle Aged; Neoplasms; Positron Emission Tomography Computed Tomography; Radiopharmaceuticals | 2018 |
Absence of early metabolic response assessed by 18F-FDG PET/CT after initiation of antifibrotic drugs in IPF patients.
Topics: Aged; Animals; Antineoplastic Agents; Female; Fibrosis; Fluorodeoxyglucose F18; Humans; Idiopathic Pulmonary Fibrosis; Indoles; Male; Mice; Mice, Inbred C57BL; Middle Aged; Positron Emission Tomography Computed Tomography; Prospective Studies; Pyridones | 2019 |
Areas of normal pulmonary parenchyma on HRCT exhibit increased FDG PET signal in IPF patients.
Topics: Aged; Aged, 80 and over; Case-Control Studies; Female; Fluorodeoxyglucose F18; Humans; Idiopathic Pulmonary Fibrosis; Lung; Male; Middle Aged; Multimodal Imaging; Positron-Emission Tomography; Radiopharmaceuticals; Sensitivity and Specificity; Tomography, X-Ray Computed | 2014 |
SUV as an adjunct in evaluating disease activity in idiopathic pulmonary fibrosis - a pilot study.
Topics: Aged; Biological Transport; Disease Progression; Fluorodeoxyglucose F18; Humans; Idiopathic Pulmonary Fibrosis; Lung; Male; Middle Aged; Pilot Projects; Positron-Emission Tomography; Radiography, Thoracic; Tomography, X-Ray Computed; Vital Capacity | 2014 |
Prognostic Value of Dual-Time-Point 18F-FDG PET for Idiopathic Pulmonary Fibrosis.
Topics: Aged; Aged, 80 and over; Algorithms; Disease-Free Survival; Female; Fluorodeoxyglucose F18; Humans; Idiopathic Pulmonary Fibrosis; Image Processing, Computer-Assisted; Lung; Male; Middle Aged; Positron-Emission Tomography; Predictive Value of Tests; Prognosis; Proportional Hazards Models; Prospective Studies; Radiopharmaceuticals; Risk Factors; Thorax; Tomography, X-Ray Computed | 2015 |